Surgery Partners Earnings Perspective: Return On Invested Capital Pulled from Benzinga Pro data, Surgery Partners (NASDAQ:SGRY) posted Q1 earnings of $42.80 million, an increase from Q4 of 0.23%. Sales dropped to $596.20 million, a 2.29% decrease between quarters. Benzinga · May 13, 2022
Analyst Ratings for Surgery Partners Analysts have provided the following ratings for Surgery Partners (NASDAQ:SGRY) within the last quarter: Benzinga · May 4, 2022
Recap: Surgery Partners Q1 Earnings Surgery Partners (NASDAQ:SGRY) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Benzinga · May 3, 2022
Airbnb And 3 Other Stocks Insiders Are Selling Although gold futures traded higher this morning on Tuesday, there were a few notable insider trades. Benzinga · Apr 26, 2022
Where Surgery Partners Stands With Analysts Within the last quarter, Surgery Partners (NASDAQ:SGRY) has observed the following analyst ratings: Benzinga · Mar 2, 2022
Surgery Partners: Q4 Earnings Insights Surgery Partners (NASDAQ:SGRY) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Benzinga · Feb 28, 2022
Analyst Ratings For Surgery Partners Over the past 3 months, 6 analysts have published their opinion on Surgery Partners (NASDAQ:SGRY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. Benzinga · Jan 26, 2022